BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Cubist Pharmaceuticals, Inc. (NQ: CBST)
63.95 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(CBST) Community Analysis from
April 19, 2014
(Stock Blog Hub, 3/5/13)
Recently, Cubist Pharmaceuticals Inc. (CBST) received some encouraging news when the US Food and Drug Administration (FDA) designated its antibiotic candidate...(read more)
(, 11/12/11)
On 10/24/2011 Cubist (click for archive of my blog posts re CBST) announced a buyout of Adolor(click for research page) This deal surprised many people, but in hindsight...(read more)
(Benzinga, 10/31/11)
Earlier this week, Cubist Pharmaceuticals announced that they would acquire Adolor Corp for $4.25/share. The deal carried an interested provision, in which Adolor's...(read more)
Cubist Pharmaceuticals (CBST) Company Overview
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here